Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2025 08:00 ET | Source: CERo Therapeutics Holdings, Inc.

CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)

Completion of DLT observation period for Cohort 1; first patient in Cohort 2 dosed at higher cell level; additional dosing in Cohort 1 SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) --...
December 16, 2025 08:45 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and...
December 16, 2025 07:15 ET | Source: Token Cat Limited

Token Cat Limited Announces Execution of a Master Service Agreement with Better Now New York Inc to Develop a 30MW AI Data Center in the United States

Beijing, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Token Cat Limited (Nasdaq: TC) (the “Company” or “TC”) today announced that it has entered into a master service agreement with Better Now New York Inc....
December 15, 2025 08:07 ET | Source: Bleichmar Fonti & Auld

JEF STOCK DROP ALERT: Jefferies Financial Group Inc. SEC Probe Triggers Securities Fraud Investigation – Contact BFA Law if You Suffered Losses on Your Investment

Jefferies Financial Group Inc. SEC Probe Triggers Securities Fraud Investigation – Contact BFA Law if You Suffered Losses on Your Investment
December 12, 2025 08:32 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment

Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery...
December 12, 2025 06:32 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Vancouver, Canada, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery...
December 11, 2025 22:13 ET | Source: Treasure Global Inc.

Treasure Global Announced Closing of USD 2,500,000 Registered Direct Offering of Common Stock

KUALA LUMPUR, Malaysia, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced the...
December 11, 2025 07:00 ET | Source: Purple Biotech Ltd.

Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...
December 10, 2025 09:00 ET | Source: Treasure Global Inc.

Treasure Global Raises USD 2,500,000 Through Registered Direct Offering of Common Stock

KUALA LUMPUR, Malaysia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced that...
December 09, 2025 07:00 ET | Source: Triller Group Inc.

ILLR Secures Nasdaq Listing Extension with Clear Path to Full Compliance

Los Angeles, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Triller Group Inc. (Nasdaq: ILLR) (“Triller Group”, or “the Company”) announced today that the Nasdaq Hearings Panel has granted an extension period...